Sep 4, 2020

Medtronic EVP & CFO Karen L. Parkhill To Participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference on Thursday, September 10, 2020.

DUBLIN, Sept. 4, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference on Thursday, September 10, 2020.

Karen Parkhill, executive vice president and chief financial officer of Medtronic, will answer questions about the company beginning at 10:40 a.m. EDT (9:40 a.m. CDT).

A live webcast of the event will be available on September 10, 2020, by clicking on the Investors Events link at http://investorrelations.medtronic.com. An archive of the session will be available on the same webpage later in the day.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. 

Contacts:

 
   

Erika Winkels

Ryan Weispfenning

Public Relations

Investor Relations

+1-763-526-8478

+1-763-505-4626

 

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/medtronic-evp--cfo-karen-l-parkhill-to-participate-in-the-wells-fargo-securities-2020-virtual-healthcare-conference-301124317.html

SOURCE Medtronic plc